Skip to content

Clinical trials

Trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Country / region: Denmark Clear all

12,800 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200025
200159
200284
2003120
2004183
2005274
2006341
2007314
2008390
2009428
2010418
2011533
2012512
2013571
2014592
2015584
2016570
2017666
2018718
2019713
2020760
2021800
2022649
2023663
2024684
2025574
2026402

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7,798
Unknown status1,544
Recruiting1,426
Active, not recruiting765
Terminated751
Not yet recruiting212
Withdrawn147
Enrolling by invitation123
Suspended22
Approved for marketing8
No longer available4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Aarhus1,185
Rigshospitalet, Denmark959
Odense University Hospital443
University of Copenhagen411
University of Southern Denmark303
Hvidovre University Hospital281
Aarhus University Hospital275
Bispebjerg Hospital261
AstraZeneca217
Zealand University Hospital216

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2463
Obesity345
Diabetes Mellitus289
Neoplasms275
Pulmonary Disease, Chronic Obstructive237
Pain232
Breast Neoplasms217
Heart Failure207
Cardiovascular Diseases196
Diabetes Mellitus, Type 1193

Trials

Showing 76 to 100 of 12,800. Each trial links to its page on Pharma Observatory.

12,700 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.